Format

Send to

Choose Destination
Pediatr Infect Dis J. 2012 Apr;31(4):409-0. doi: 10.1097/INF.0b013e318247f3e0.

Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States.

Author information

1
Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA. yamad@healthcare.uiowa.edu

Abstract

Macrolide-resistant Mycoplasma pneumoniae is widespread in Asia, and severe cases of pneumonia have been described in children. Little information is available about the resistance pattern in the United States. We collected respiratory samples from 49 patients with Mycoplasma infection in the central United States between 2007 and 2010. We found a macrolide resistance rate of 8.2%. Resistance should be considered when patients with M. pneumoniae infection do not have a satisfactory response to macrolides. Alternative antibiotics include tetracyclines or fluoroquinolones.

PMID:
22209916
DOI:
10.1097/INF.0b013e318247f3e0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center